Preliminary analysis of chemotherapy waste cost

Authors

  • Adriano Hyeda Universidade Federal do Paraná (UFPR), Pontifícia Universidade Católica do Paraná (PUC-PR); Instituto Superior de Administração e Economia da Fundação Getúlio Vargas (ISAE/FGV) – Curitiba (PR), Brasil.
  • Élide Costa PUC-PR; ISAE/FGV – Curitiba (PR), Brasil.

Keywords:

neoplasia, chemotherapy, health services administration, good manipulation practices, medical waste

Abstract

INTRODUCTION: Frequently, there are chemotherapy wastes in drug´s preparation for application to the patient. OBJECTIVE: The aim of this study was analyzing chemotherapy waste cost at the drug´s preparation. METHODS: It has been conducted a cross-sectional observational study. The study data were obtained from chemotherapy’s requests by oncologists linked to a health insurance plan. It has been calculated the dose of chemotherapy waste in each application, considering the dose prescribed by the doctor and the drug´s dosage form. RESULTS: There were 176 patients with cancer diagnosed of which 106 patients underwent treatment with chemotherapy. There were 1.284 applications for anticancer medications. It was found a total of 63.824 mg chemotherapy waste. The chemotherapy waste cost found was R$ 448.397,00. The average cost of chemotherapy waste for patient was R$ 4.607,00 and R$ 380,00 for application´s day. CONCLUSION: The economic impact of chemotherapy waste in cancer treatment was significant. The management measures at chemotherapy preparation may be a strategy to reduce the drugs waste.

Downloads

Download data is not yet available.

Published

2014-12-20

How to Cite

Hyeda, A., & Costa, Élide. (2014). Preliminary analysis of chemotherapy waste cost. Jornal Brasileiro De Economia Da Saúde, 6(3), 150–155. Retrieved from https://www.jbes.com.br/index.php/jbes/article/view/360

Issue

Section

Artigos